Randall Hyer from Dynavax: Developing a Vaccine to Prevent Hepatitis B in Diabetes Patients
JUNE 19, 2016
Research in the medical field covers a wide range of conditions and ways to not only treat them but also prevent them. Research is being done on a new vaccine for hepatitis B which has shown to be effective in patients with diabetes.
Randall N. Hyer, MD, PhD, MPH, from Dynavax discussed a vaccine his company is developing that would prevent the spread of hepatitis B from this patient population and others. Hyer said patients with diabetes are succeptible to this form of hepatitis for a number of circumstances but with the right care it can be largely preventable. Hyer discussed the vaccine during the American Diabetes Association's annual meeting in New Orleans.